In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes

Graves, 2001, In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones, Cornea, 20, 301, 10.1097/00003226-200104000-00012 O'Brien, 1995, Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the Bacterial Keratitis Study Research Group, Arch Ophthalmol, 113, 1257, 10.1001/archopht.1995.01100100045026 Mallari, 2001, Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis, Am J Ophthalmol, 131, 131, 10.1016/S0002-9394(00)00642-5 Bekoe, 1999, Effects of ciprofloxacin, ofloxacin, and gentamicin on corneal cells and wound healing, Invest Ophthalmol Vis Sci, 40, S548 Kovoor, 2004, Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy, Eye Contact Lens, 30, 90, 10.1097/01.ICL.00000117255.97190.98 Nelson, 1990, Corneal epithelial wound healing: a tissue culture assay on the effect of antibiotics, Curr Eye Res, 9, 277, 10.3109/02713689009044524 Scuderi, 2003, In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells, Cornea, 22, 468, 10.1097/00003226-200307000-00014 Bezwada, 2008, Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells, Curr Med Res Opin, 24, 419, 10.1185/030079908X261005 Arici, 2000, Adverse effects of topical antiglaucoma drugs on the ocular surface, Clin Exp Ophthalmol, 28, 113, 10.1046/j.1442-9071.2000.00237.x Costagliola, 2001, Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis, Graefes Arch Clin Exp Ophthalmol, 239, 809, 10.1007/s004170100328 Yalvac, 1995, Effects of antiglaucoma drugs on ocular surface, Acta Ophthalmol Scand, 73, 246, 10.1111/j.1600-0420.1995.tb00277.x Noecker, 2001, Effects of common ophthalmic preservatives on ocular health, Adv Ther, 18, 205, 10.1007/BF02853166 Paugh, 1998, Preservative effect on epithelial barrier function measured with a novel technique, Adv Exp Med Biol, 438, 731, 10.1007/978-1-4615-5359-5_103 Haas, 2011, In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride, J Antimicrob Chemother, 66, 840, 10.1093/jac/dkq531 Hesie, 2009, Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains, J Ocul Pharmacol, 25, 329, 10.1089/jop.2009.0031 Seitz, 1996, In vitro effects of aminoglycosides and fluoroquinolones on keratocytes, Invest Ophthalmol Vis Sci, 37, 656 Pellegrini-Giampietro, 1999, 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia, Eur J Neurosci, 11, 3637, 10.1046/j.1460-9568.1999.00786.x Kim, 2003, Apoptosis in keratocytes caused by mitomycin C, Invest Ophthalmol Vis Sci, 44, 1912, 10.1167/iovs.02-0977 Cutarelli, 1991, Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity, Curr Eye Res, 10, 557, 10.3109/02713689109001764 Osato, 1989, The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates, Am J Ophthalmol, 108, 380, 10.1016/S0002-9394(14)73305-7 Serdarevic, 1993, Role of the fluoroquinolones in ophthalmology, Int Ophthalmol Clin, 33, 163, 10.1097/00004397-199303310-00014 Sosa, 2008, Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells, Cornea, 27, 930, 10.1097/ICO.0b013e31816f27ab Zhang, 2008, Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells, Curr Eye Res, 33, 923, 10.1080/02713680802478704 Matsumoto, 2006, Comparative toxicity of fluoroquinolone antibiotics on corneal cells in vitro, Cornea, 25, S1, 10.1097/01.ico.0000151543.15736.93 Leonardi, 2006, In vitro effects of fluoroquinolone and aminoglycoside antibiotics on human keratocytes, Cornea, 25, 85, 10.1097/01.ico.0000164782.10667.ed Snyder, 1998, Keratocytes: no more the quiet cells, J Am Optom Assoc, 69, 180 Burstein, 1980, Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas, Invest Ophthalmol Vis Sci, 19, 308 Gasset, 1974, Cytotoxicity of ophthalmic preservatives, Am J Ophthalmol, 78, 98, 10.1016/0002-9394(74)90016-6 Gasset, 1977, Benzalkonium chloride toxicity to the human cornea, Am J Ophthalmol, 84, 169, 10.1016/0002-9394(77)90849-2 Dutot, 2006, Fluoroquinolone eye drop-induced cytotoxicity: role of preservative in P2X7 cell death receptor activation and apoptosis, Invest Ophthalmol Vis Sci, 47, 2812, 10.1167/iovs.06-0224 Gootz, 2009, Bactericidal assays for fluoroquinolones, Methods Mol Biol, 95, 185 Baudouin, 1999, Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies, Ophthalmology, 106, 556, 10.1016/S0161-6420(99)90116-1 de Saint, 1999, Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells, Invest Ophthalmol Vis Sci, 40, 619 Tripathi, 1989, Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro, Lens Eye Toxic Res, 6, 395